735 related articles for article (PubMed ID: 18668044)
21. The antigenic structure of the HIV gp120 envelope glycoprotein.
Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
Kumar R; Ozorowski G; Kumar V; Holden LG; Shrivastava T; Patil S; Deshpande S; Ward AB; Bhattacharya J
J Biol Chem; 2017 Sep; 292(38):15849-15858. PubMed ID: 28743743
[TBL] [Abstract][Full Text] [Related]
23. Structural definition of a conserved neutralization epitope on HIV-1 gp120.
Zhou T; Xu L; Dey B; Hessell AJ; Van Ryk D; Xiang SH; Yang X; Zhang MY; Zwick MB; Arthos J; Burton DR; Dimitrov DS; Sodroski J; Wyatt R; Nabel GJ; Kwong PD
Nature; 2007 Feb; 445(7129):732-7. PubMed ID: 17301785
[TBL] [Abstract][Full Text] [Related]
24. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
[TBL] [Abstract][Full Text] [Related]
25. Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops.
Kwon YD; Finzi A; Wu X; Dogo-Isonagie C; Lee LK; Moore LR; Schmidt SD; Stuckey J; Yang Y; Zhou T; Zhu J; Vicic DA; Debnath AK; Shapiro L; Bewley CA; Mascola JR; Sodroski JG; Kwong PD
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5663-8. PubMed ID: 22451932
[TBL] [Abstract][Full Text] [Related]
26. Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers.
Khayat R; Lee JH; Julien JP; Cupo A; Klasse PJ; Sanders RW; Moore JP; Wilson IA; Ward AB
J Virol; 2013 Sep; 87(17):9865-72. PubMed ID: 23824817
[TBL] [Abstract][Full Text] [Related]
27. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement.
Alsahafi N; Anand SP; Castillo-Menendez L; Verly MM; Medjahed H; Prévost J; Herschhorn A; Richard J; Schön A; Melillo B; Freire E; Smith AB; Sodroski J; Finzi A
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021898
[TBL] [Abstract][Full Text] [Related]
28. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
J Virol; 2017 May; 91(10):. PubMed ID: 28250125
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations.
Ma X; Lu M; Gorman J; Terry DS; Hong X; Zhou Z; Zhao H; Altman RB; Arthos J; Blanchard SC; Kwong PD; Munro JB; Mothes W
Elife; 2018 Mar; 7():. PubMed ID: 29561264
[TBL] [Abstract][Full Text] [Related]
30. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes.
Li W; Qin Z; Nand E; Grunst MW; Grover JR; Bess JW; Lifson JD; Zwick MB; Tagare HD; Uchil PD; Mothes W
Nature; 2023 Nov; 623(7989):1026-1033. PubMed ID: 37993716
[TBL] [Abstract][Full Text] [Related]
33. Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
Castillo-Menendez LR; Nguyen HT; Sodroski J
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429345
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
Zhang MY; Yuan T; Li J; Rosa Borges A; Watkins JD; Guenaga J; Yang Z; Wang Y; Wilson R; Li Y; Polonis VR; Pincus SH; Ruprecht RM; Dimitrov DS
PLoS One; 2012; 7(9):e44241. PubMed ID: 22970187
[TBL] [Abstract][Full Text] [Related]
35. Restraining the conformation of HIV-1 gp120 by removing a flexible loop.
Rits-Volloch S; Frey G; Harrison SC; Chen B
EMBO J; 2006 Oct; 25(20):5026-35. PubMed ID: 17006538
[TBL] [Abstract][Full Text] [Related]
36. PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.
Falkowska E; Ramos A; Feng Y; Zhou T; Moquin S; Walker LM; Wu X; Seaman MS; Wrin T; Kwong PD; Wyatt RT; Mascola JR; Poignard P; Burton DR
J Virol; 2012 Apr; 86(8):4394-403. PubMed ID: 22345481
[TBL] [Abstract][Full Text] [Related]
37. CD4-induced activation in a soluble HIV-1 Env trimer.
Guttman M; Garcia NK; Cupo A; Matsui T; Julien JP; Sanders RW; Wilson IA; Moore JP; Lee KK
Structure; 2014 Jul; 22(7):974-84. PubMed ID: 24931470
[TBL] [Abstract][Full Text] [Related]
38. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
Heredia JD; Park J; Choi H; Gill KS; Procko E
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
[TBL] [Abstract][Full Text] [Related]
39. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
[TBL] [Abstract][Full Text] [Related]
40. Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion.
Wang H; Barnes CO; Yang Z; Nussenzweig MC; Bjorkman PJ
Cell Host Microbe; 2018 Oct; 24(4):579-592.e4. PubMed ID: 30308160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
